Sensorion News - ALSEN | Aktien Euronext

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Sensorion reçoit une recommandation positive du Comité de Surveillance des Données concernant Audiogene, son essai clinique de Phase 1/2 avec le SENS-501

Le comité recommande la poursuite de l’essai clinique Audiogene à la suite de la revue des données de sécurité de la première cohorte La fin du...

Sensorion Announces Its Participation in Several Investor Conferences to be Held in March

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of...

Sensorion Announces Its Participation In Several Congresses To Be Held In March

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of...

Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 48th Annual Midwinter Meeting

Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel...

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Sensorion (ALSEN)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

ALSEN Nachrichten

Sensorion reçoit une recommandation positive du Comité de Surveillance des Données concernant Audiogene, son essai clinique de Phase 1/2 avec le SENS-501

Sensorion Announces Its Participation in Several Investor Conferences to be Held in March

Sensorion Announces Its Participation In Several Congresses To Be Held In March

Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 48th Annual Midwinter Meeting

Sensorion Announces Completion of Enrollment of The First Cohort of The Audiogene Phase 1/2 Gene Therapy Clinical Trial

Sensorion Reports Data in the Audiogene Phase 1/2 Gene Therapy Clinical Trial

Sensorion annonce sa participation à la 43ème conférence annuelle J.P. Morgan Healthcare Conference

Sensorion Announces Its Participation in Upcoming Investor Conferences to be Held in November 2024

ALSEN Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Sensorion (ALSEN) News

Sensorion (ALSEN)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

ALSEN Nachrichten

Sensorion reçoit une recommandation positive du Comité de Surveillance des Données concernant Audiogene, son essai clinique de Phase 1/2 avec le SENS-501

Sensorion Announces Its Participation in Several Investor Conferences to be Held in March

Sensorion Announces Its Participation In Several Congresses To Be Held In March

Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 48th Annual Midwinter Meeting

Sensorion Announces Completion of Enrollment of The First Cohort of The Audiogene Phase 1/2 Gene Therapy Clinical Trial

Sensorion Reports Data in the Audiogene Phase 1/2 Gene Therapy Clinical Trial

Sensorion annonce sa participation à la 43ème conférence annuelle J.P. Morgan Healthcare Conference

Sensorion Announces Its Participation in Upcoming Investor Conferences to be Held in November 2024

ALSEN Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen